Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Siga Technologies, Inc.
A pharmaceutical company that makes antiviral drugs for serious infectious diseases and biothreats, best known for TPOXX (tecovirimat), the first drug approved in the U.S. to treat smallpox and stockpiled by governments against bioterror threats. Founded in 1995 by Steven Oliveira and based in New York City, it works with U.S. agencies like BARDA on medical countermeasures. Fun fact: since smallpox was eradicated, TPOXX won approval under the FDA's "Animal Rule," which allows a drug to be approved on animal studies when human trials aren't possible.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
8.01 Other Events
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits